Array Patents definition

Array Patents means any Patent Rights Controlled by Array and/or its Affiliates as of the Effective Date or thereafter during the term of this Agreement having claims covering Varlitinib and/or Product, their use, composition, formulation, preparation, manufacture or Commercialization in the Field. For the avoidance of doubt, “Array Patents” shall include Array’s ownership interest in any Joint Patents.

Array Patents means all patents and patent applications owned or Controlled by Array.

Array Patents means all Patents which claim any Array Technology and that are Controlled by Array during the Exclusivity Period, but shall exclude any claims of an Optimization Patent. For purposes of this definition, "controlled" shall mean the ability to grant a license or sublicense as provided for in Section 8.1 below.

Examples of Array Patents in a sentence

• ASLAN has a right to make recommendations in relation to the filing, prosecution, maintenance, enforcement and defense of the Array Patents and Array shall and shall consider, in good faith, the interests of ASLAN in assessing such recommendations.

• Oncothyreon or Array, as the case may be, shall control the Prosecution and Maintenance of Patent Rights within the Oncothyreon Patents and the Array Patents, respectively, in each case at its own cost and using counsel of its choice and in such countries as such Party determines is appropriate.

• Array agrees to keep Ono generally informed as to the course of such patent filing, prosecution, maintenance or other proceedings with respect to Array Patents.

• The Parties shall keep one another informed of the status of their respective activities regarding any litigation or settlement thereof concerning the Array Patents or the Array Know-How within the Ono Territory, and shall assist one another and cooperate in any such litigation at the other’s reasonable request (including joining as a party plaintiff to the extent necessary and requested by the other Party).

• We focused on PRC2, as the frequent dysregulation of PRC2 function in can- cer has led to the development of multiple small molecule in- hibitors that could be used in a TRACE assay: UNC1999 and GSK343 inhibit the catalytic function of enhancer of zeste ho- molog 2 (EZH2) and thus prevent H3K27me3 deposition (Konze et al., 2013; Verma et al., 2012), while EED226 blocks H3K27me3 recognition by embryonic ectoderm development protein (EED) (Qi et al., 2017).

More Definitions of Array Patents

Array Patents means all Patents owned or Controlled by Array (a) as of the Effective Date, or (b) during the Term of this Agreement to the extent that such Patents claim Array Know-How, in each case that: (i) claim a Collaboration Compound or a Collaboration Back-Up Compound (including the composition of matter, or manufacture or any use thereof); and (ii) are necessary for Celgene to exercise the rights licensed to it under the Agreement or perform its obligations with respect to Collaboration Compounds, Collaboration Back-Up Compounds and Licensed Products under the Agreement. For the purposes of the license granted in Section 5.1.2, Array Patents shall also include all Patents owned or Controlled by Array as of the Effective Date covering inventions that are necessary for the discovery, development, or use of Compounds, Development Compounds and Development Back-Up Compounds. Notwithstanding Sections 1.5.1 and 1.5.2 above, the Array Technology shall not include Collaboration Patents or Collaboration Know-How.

Array Patents means the Patents Controlled by Array or its Controlled Affiliates as of the Effective Date or during the term of this Agreement that: (a) are listed on Exhibit 1.5; or (b) but for the license granted under this Agreement, would be infringed by the Development, Manufacturing, registration, packaging, or Commercialization of a Product in the Ono Territory (including the identification of patients who would benefit from the Product based on the presence or absence of selected biomarkers); and (c) all additions, divisions, continuations, substitutions, re-issues, re-examinations, registrations, patent term extensions, supplemental protection certificates, and renewals of any the Patents listed on Exhibit 1.5 or to the extent the same would satisfy the requirements of subsection (b) above.

Array Patents means the Patents set out in Exhibit 1.5.

Array Patents means the following intellectual property rights which claim Array Technology and which are owned or Controlled by Array, in whole or in part: (a) any and all patent applications (including all divisionals, continuations or continuations-in-part) filed or having legal force in any country within the Territory, (b) any and all patents that have issued or in the future issue from the foregoing patent applications, including utility, model and design patents and certificates of invention, and (c) any and all extensions or restorations by existing or future extension or restoration mechanisms, including without limitation Supplementary Protection Certificates or the equivalent thereof, substitutions, confirmations, reregistrations, reexaminations, revalidations, reissues, renewals, extensions or additions to any such foregoing patent applications and patents.

Array Patents means Patents covering Array Contributed Technology or Array Collaboration Technology.

Array Patents shall include Array’s ownership interest in any Joint Patents.

Array Patents means, subject to Section 5.4.1 or 5.4.3, as applicable, (i) all Patents Controlled by Array as of the Effective Date that are reasonably necessary or useful for the Parties to conduct their respective activities under the Discovery Program and Global Development Plan and for Amgen to discover, research, develop, make, have made, use, import, offer to sell, sell and otherwise exploit Compounds or Products, (ii) Array’s interest in Patents claiming Collaboration Technology, and (iii) any other Patents Controlled by Array during the term of this Agreement that are (A) reasonably necessary or directly useful for the discovery, research, development, manufacture, use or sale of Compounds or Products, including the ARRY-403 Product as manufactured and formulated by Array as of the Effective Date (and in any event shall include Patents that claim the composition of matter or use of a Compound), or (B) that are reasonably necessary or directly useful for the conduct of the Discovery Program; provided, however, that with respect to Patents licensed by Array from Third Parties that are within the foregoing clause (iii), and not clause (i) or (ii), such Patents shall not be included within the Array Patents for purposes of the licenses to Amgen hereunder unless and until Amgen agrees with Array in writing to assume such payment obligations as they relate to Compounds and Products. Array agrees to provide information regarding such payments (if any) to Third Parties upon Amgen’s request.